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Abstract
Accumulating evidence suggests that increased visit-to-visit variability (VVV) of blood pressure is
associated with stroke. No study has examined the association between VVV of blood pressure
and stroke in postmenopausal women, and scarce data exists as to whether this relation is
independent of the temporal trend of blood pressure. We examined the association of VVV of
blood pressure with stroke in 58,228 postmenopausal women enrolled in the Women's Health
Initiative. Duplicate blood pressure readings, which were averaged, were taken at baseline and at
each annual visit. VVV was defined as the standard deviation about the participant's mean systolic
blood pressure (SBP) across visits (SD), and about the participant's regression line with SBP
regressed across visits (SDreg). Over a median follow-up of 5.4 years, 997 strokes occurred. In an
adjusted model including mean SBP over time, the hazard ratios (95% CI) of stroke for higher
quartiles of SD of SBP compared to the lowest quartile (referent) were 1.39 (1.03-1.89) for
quartile 2, 1.52 (1.13-2.03) for quartile 3, and 1.72 (1.28-2.32) for quartile 4 (P trend<0.001). The
relation was similar for SDreg of SBP quartiles in a model that additionally adjusted for the
temporal trend in SBP (P trend<0.001). The associations did not differ by stroke type (ischemic
vs. hemorrhagic). There was a significant interaction between mean SBP and SDreg on stroke
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with the strongest association seen below 120 mmHg. In postmenopausal women, greater VVV of
SBP was associated with increased risk of stroke, particularly in the lowest range of mean SBP.
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Introduction
In the United States, stroke is the fourth leading cause of death1 and the leading cause of
disability.2 Women have lower age-adjusted stroke incidence than men.2 However, because
of the longer life expectancy in women, the lifetime risk of stroke is greater in women
compared with men. Women also account for a large proportion of stroke deaths and
disability after stroke.2 A better understanding of the determinants of stroke in women has
substantial implications in both the clinical and public health context.
Elevated blood pressure is a risk factor for stroke.3 The prognostic value of blood pressure is
based on the traditional method of obtaining auscultatory measurements in a clinic setting,
typically averaged over several visits.4 It is generally believed that readings obtained in this
manner are limited by variability observed from one visit to the next.5 However, there is
accumulating evidence that increased visit-to-visit variability (VVV) of blood pressure is
associated with a higher risk of stroke,6 coronary heart disease (CHD),7 and all-cause
mortality,8, 9 associations that are independent of average blood pressure over time and other
possible explanatory factors.
Studies reporting on VVV of blood pressure and prognosis have been relatively small8, 9 and
included select patients who were already at high cardiovascular disease (CVD) risk.6 Only
one published study has specifically reported on stroke as an outcome.6 This latter study
included patients with prior transient ischemic attack, stroke, or multiple CVD risk factors.6
Further, although individuals who have an increasing blood pressure over time may have a
higher risk of stroke, scarce data exist as to whether the relation of VVV of blood pressure
and stroke is independent of blood pressure increases over time.6 Finally, no study has
previously examined these relations in postmenopausal women, who are at increased risk for
stroke.
We determined whether VVV of blood pressure is associated with stroke, and whether this
relation is independent of the mean and temporal change in blood pressure over time, in a
large well-characterized cohort of postmenopausal women with a wide range of CVD risk
enrolled in the Women's Health Initiative (WHI).
Methods
Sample Population
WHI is a multi-center study of 161,808 postmenopausal women aged 50 to 79 years
consisting of overlapping clinical trials (CTs) and an observational study (OS).10 This
analysis restricts the population to women enrolled in the CT components (N=68,132), and
excludes women who did not have blood pressure assessed at the baseline visit and at least
two follow-up visits up to the Year 3 visit, had experienced an incident stroke and/or
mortality event prior to their Year 3 visit, or did not have a Year 3 visit or any subsequent
follow-up, leaving a final sample size of 58,228. The online Data Supplement (please see
http://hyper.ahajournals.org) provides further details on the design of WHI and how the
sample for the current analyses was selected. The protocol was approved by institutional
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review boards of the participating institutions; all trial participants provided written
informed consent.
Blood pressure and Heart Rate Measurement
Blood pressure and heart rate were measured at baseline and each annual study visit by
certified staff with the use of standardized procedures and instruments. Appropriate cuff
bladder size was determined at each visit based on arm circumference. Blood pressure was
measured in the right arm with a mercury sphygmomanometer after the participant was
seated and had rested for 5 minutes; 2 measures, taken 30 seconds apart, were recorded. The
blood pressure at each visit was defined as the average of the 2 readings. Heart rate was
measured manually once at each visit.
Outcome Ascertainment
Detailed definitions and methods for ascertaining and classifying outcomes have been
published.11 Briefly, fatal and non-fatal strokes were verified by review of medical records
by centrally trained physician adjudicators at each center. Stroke cases were centrally
adjudicated at the WHI Clinical Coordinating Center. Stroke was defined as the rapid onset
of a neurologic deficit lasting more than 24 hours, unless death supervened or a lesion
compatible with acute stroke was evident on computed tomography or magnetic resonance
imaging scan. For this analysis, the primary outcome was defined as the occurrence of a
fatal or non-fatal ischemic or hemorrhagic stroke. Ischemic stroke was defined as the
occlusion of cerebral or pericerebral arteries with infarction not resulting from a procedure
(cerebral thrombosis, cerebral embolism, lacunar infarction). Hemorrhagic stroke was
defined as subarachnoid hemorrhage, intracerebral hemorrhage, or other/unspecified intra-
cranial hemorrhage not resulting from a procedure (nontraumatic epidural hemorrhage or
subdural hemorrhage).
Statistical Analyses
VVV of blood pressure, the primary exposure, was defined as the standard deviation (SD)
about the participant's mean systolic blood pressure (SBP) across visits.6, 8, 9 VVV of blood
pressure was also defined as the standard deviation about the participant's regression line
(SDreg) with SBP regressed across visits. The estimation of SD assumes that a participant's
blood pressure is constant over follow-up, and the estimation of SDreg assumes a linear
temporal trend. The online Data Supplement provides further details on the definitions of
SD and SDreg. Other measures of VVV, such as coefficient of variation and variation
independent of the mean,6, 8, 9 were not pursued because these measures were highly
correlated with SD (r=0.97 for the correlation between SD and coefficient of variation, and
r=0.90 for the correlation between SD and variation independent of the mean), and
therefore, likely represent the same underlying domain of blood pressure variability.
Baseline characteristics of participants were examined by SD of SBP quartiles. Tests for
linear trend across quartiles were adjusted for age, race/ethnicity, and randomization
assignment in the hormone therapy trial. Primary analyses used time-to-event methods based
on the Cox regression model with time defined as the number of days from the third annual
visit to the first postrandomization diagnosis of stroke. Stroke events were included through
the protocol-specified termination date of March 31, 2005. The online Data Supplement
provides details on how covariates were ascertained and defined. An initial model (Model 1)
provided hazard ratios for stroke associated with SD of SBP quartiles, with the lowest
quartile serving as the referent, adjusting for age, race/ethnicity and allowing the hazard
function to vary by 5-year age groups. Model 2 included covariates in Model 1 plus the
baseline status of diabetes, high cholesterol, smoking status, education level, prior hormone
therapy use, physical activity level, body mass index, history of CHD, history of atrial
Shimbo et al. Page 3













fibrillation, left ventricular hypertrophy on 12-lead electrocardiogram, and additional
stratification on history of stroke and hormone therapy trial assignment; mean SBP across
visits (time-dependent variable); mean heart rate across visits (time-dependent variable), and
antihypertensive medication use across visits (time-dependent variable). Antihypertensive
medication use across visits was defined as never used (no antihypertensive medication use
at baseline and all available follow-up visits, used at all visits (on antihypertensive
medications at baseline and all available follow-up visits), newly started during follow-up
(on no antihypertensive medications at baseline, and on antihypertensive medications at one
of the follow-up exams), and other (not in one of the above categories). To account for
systematic changes in blood pressure, the final model (Model 3) used SDreg of SBP as the
exposure variable, and included the covariates in Model 2 plus a participant's linear change
in SBP. All time-dependent variables including SD and SDreg were based on measures
through Year 3, and later updated at each subsequent visit while a participant remained at
risk. Models 1 to 3 were also fit with the corresponding exposure variable, SD or SDreg,
modeled as a continuous variable.
Subgroup analyses tested interactions between SDreg of SBP and several baseline
characteristics within the final Cox regression model. An additional analysis was performed
in which mean diastolic blood pressure (DBP) across visits was added to Model 3. The
relations across quartiles of SDreg of SBP remained unchanged. Similar findings were
observed when SD of DBP was added to the multivariable model. Lastly, results did not
change when mean pulse pressure across visits was added to Model 3 instead of mean DBP
across visits. We do not report further on these analyses, as the results do not alter the
primary findings of the study.
All statistical tests were two sided and P values <0.05 were considered to be statistically
significant. Analyses were performed by SAS statistical software version 9.2 (SAS Inc,
Cary, NC) and figures were constructed with R version 2.11.12
Results
Characteristics and Correlates of VVV of SBP
The means (SD) of the SD of SBP and of SBP across visits were 10.9 (4.5) mm Hg and
125.8 (12.9) mm Hg respectively. Higher quartiles of SD of SBP were associated with older
age; higher body mass index; higher mean SBP, DBP and pulse pressure; a small decrease in
mean heart rate; randomization to the hormone therapy component; Black/African American
race; not having successfully obtained a college degree or higher; antihypertensive
medication use across visits; history of hypertension; statin, aspirin and anticoagulation use;
history of diabetes and high cholesterol; smoking status; the presence of left ventricular
hypertrophy; history of CHD; history of stroke; history of atrial fibrillation; and lower
physical activity (Table S1 in the online Data Supplement).
Relation Between VVV of SBP and Stroke
The mean (SD) number of visits that were used to estimate SD of SBP was 7.9 (1.8). Over a
median (IQR) follow-up of 5.4 (1.7) years, a total (annualized rate) of 997 (0.32%) strokes
occurred during 315,789 person years of observation. Of the primary stroke events, 81.3%
were ischemic and 18.7% were hemorrhagic. In an age-stratified model adjusted for age and
race/ethnicity (Model 1, top panel, Table 1), higher quartiles of the SD of SBP were
significantly associated with an increasing risk of stroke. After further adjustment for CVD
risk factors, prevalent CVD, mean SBP, mean heart rate, and antihypertensive medication
use (Model 2, top panel, Table 1), the relation between SD of SBP and stroke was
attenuated, but the trend across quartiles remained significant. In a fully adjusted model that
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also accounted for linear change of SBP (Model 3, top panel, Table 1), increasing quartiles
of SDreg of SBP were significantly related to higher stroke risks. In this latter model, a
steeper slope of SBP across visits was also associated with a higher risk of stroke (P <0.05).
A similar pattern of results was observed when SD (Models 1 and 2) or SDreg (Model 3) of
SBP was expressed as a continuous variable (bottom panel, Table 1). The hazard ratios
(95% CI) for each 5 mmHg increase in SD of SBP did not differ by stroke type in Model 2:
1.15 (95% CI 1.07 - 1.25) for ischemic stroke and 1.18 (95% CI 1.00 - 1.40) for
hemorrhagic stroke (heterogeneity P = 0.78). The hazard ratios (95% CI) for each 5 mmHg
increase in SDreg of SBP also did not differ by stroke type in Model 3: 1.12 (95% CI 1.04 -
1.21) for ischemic stroke and 1.14 (95% CI 0.97 - 1.34) for hemorrhagic stroke
(heterogeneity P = 0.86).
Subgroup Analyses
As Table S2 shows (see online Data Supplement), there was a significant interaction
(interaction P = 0.005) between mean SBP across visits and SDreg of SBP on stroke. The
relation between SDreg of SBP and stroke became stronger with decreasing levels of mean
SBP below 140 mm Hg, particularly among individuals with mean SBP <120 mm Hg. In
participants with mean SBP <120 mm Hg, the prevalence of episodic systolic hypertension
(i.e. having at least one visit with SBP >140 mm Hg) by quartiles of SDreg of SBP (<6 mm
Hg, 6-8.9 mm Hg, 9-12.9 mm Hg, and ≥13 mm Hg) was 0.1%, 0.7%, 6.2%, and 39.6%
respectively. Participants with mean SBP <120 mm Hg and who were in the highest quartile
of SDreg of SBP (≥13 mm Hg) had less than a third of their visits with SBP >140 mm Hg.
The hazard ratio for stroke was greater in younger than in older women (Table S2), although
the interaction was borderline significant (interaction P = 0.05). There was also a significant
interaction of the number of visits used to estimate SDreg of SBP on the relationship
between SDreg of SBP and stroke (Table S3 in the online Data Supplement).
Discussion
This study adds important information to the literature on VVV of blood pressure and
stroke. Higher annual VVV of SBP was associated with an increased risk of stroke,
independent of several possible explanatory factors including age, race/ethnicity, CVD risk
factors, prevalent CVD, randomization to hormone therapy, antihypertensive medication
use, and mean SBP over time.
Rothwell et al.6 showed that higher VVV of SBP was associated with stroke in four cohorts
that included more than 7,000 patients who were already at high risk for stroke including
those with previous transient ischemic attack or minor stroke. Higher VVV of SBP was also
associated with stroke in treated hypertensive patients who had at least three other CVD risk
factors or prevalent CVD enrolled in the Anglo-Scandinavian Cardiac Outcomes Trial Blood
Pressure Lowering Arm (ASCOT-BPLA).6 Our study extends these findings by
demonstrating that higher levels of annual VVV of SBP are independently associated with
an increased risk of stroke in postmenopausal women representing a broad range of CVD
risk.
VVV of blood pressure is commonly defined as SD of SBP.6, 8, 9 Since SD of SBP
represents the deviation of SBP from the mean, which is assumed to be static over time, then
it is generally true that SD of SBP is higher with a greater linear increase in SBP over time
compared with SBP that remains constant over time. Therefore, it is possible that the
association between VVV of blood pressure and stroke may be explained by increasing
blood pressure over time. However, in our study, SDreg of SBP and an increased temporal
trend in SBP were independently associated with stroke, indicating that not only is an
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increase in blood pressure over time associated with stroke, but also VVV of blood pressure
contributes to stroke in a manner that is independent of blood pressure trends. Rothwell et
al.6 similarly reported that the relation between VVV of SBP and stroke was independent of
the temporal trend in SBP. Figure 1 shows VVV and slopes of SBP in four representative
individuals in our study who have approximately the same mean SBP. These examples are
illustrative of how SD of SBP from the mean is partially determined by the temporal trend
of SBP, and that the SDreg of SBP from the regression line represents variability that is
independent of the temporal trend of SBP. Although other studies have demonstrated a
relation of VVV of blood pressure with total mortality,8, 9 cardiovascular mortality,9
increased white matter hyperintensity volume in the brain,13 and carotid intima-media
thickness,14 these studies did not examine whether the relations between VVV of blood
pressure and these outcomes were independent of a temporal trend in blood pressure.
The relation between VVV of SBP and stroke was stronger in postmenopausal women with
SBP in the lowest range (mean <120 mm Hg). SBP was greater than 140 mm Hg in minority
of visits in these participants. The VVV of SBP-stroke association was also possibly
modified by younger age – the risk of stroke was stronger in the 50-59 year age category.
Similar findings were reported in the study by Rothwell et al.6 in which the relation between
VVV of SBP and stroke was stronger in participants who had mean SBP less than the
median (∼143 mm Hg) and in those in the youngest tertile of age (<56 years). Therefore,
VVV of blood pressure may be an important determinant of stroke, particularly in
individuals who otherwise would be considered to be low risk based on their SBP and age.
As demonstrated by others,6 the risk for stroke increased with the number of visits used to
estimate VVV. The reproducibility of VVV of blood pressure may also increase with more
measurements.15, 16 Therefore, for evaluating an individual's risk associated with VVV of
blood pressure, clinicians should be wary in using only a few visits to estimate VVV. Future
studies are needed to determine the minimum number of visits required to obtain
reproducible and valid estimates of VVV. Additionally, the optimal interval between visits
(i.e. days, months, years) should also be determined.
The putative factors that explain the link between VVV of SBP and stroke are unclear.
Arterial stiffness may play a role.14 Subclinical atherosclerosis, increased wall stress,
baroreceptor dysfunction, and endothelial dysfunction are other possible
mechanisms.6, 8, 17, 18 However, it is unclear if these factors are causes or consequences of
VVV of SBP. Finally, the mechanisms into why lower SBP and younger age modified the
relation between VVV of SBP and stroke in postmenopausal women needs to be clarified in
future studies.
Finally, our study found that the relationship between VVV of SBP and stroke did not differ
by stroke type (i.e. ischemic vs. hemorrhagic). In contrast, Rothwell et al.6 found that VVV
of SBP was more predictive of ischemic than hemorrhagic strokes in treated hypertensive
participants enrolled in ASCOT-BPLA. The reasons for these divergent results are unclear.
The different populations examined as well as the substantially smaller percentage of
hemorrhagic vs. ischemic strokes in either sample may be possible explanatory factors.
The sample comprised only women, whose age was restricted to 50 to 79 years. Thus,
whether our results can be extended to men, elderly women, or younger premenopausal
remains to be determined. Further, our analyses did not consider the various classes of
antihypertensive medications that women may have been taking. Certain antihypertensive
medication classes may have differential effects on VVV of SBP.19, 20 However, the relation
of VVV of SBP with outcomes is also independent of antihypertensive medication class.6, 8
Lastly, it is possible that blood pressure readings were affected by measurement error in our
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study. However, since the presence of measurement error would have biased our results
toward the null, it is likely that the association between VVV of SBP and stroke would be
even stronger if measurement error were eliminated.
Major strengths of the study are the very large sample size, well-characterized cohort, and
the large number of strokes that were available for analysis. This allowed for the
consideration of several possible confounders in the relation between VVV of SBP and
stroke, and also the examination of this relation across various subgroups. An additional
strength of the study was the careful and standardized assessment of blood pressure and
cardiovascular risk factors in WHI, and the central adjudication of all reported stroke events
by study neurologists. Further, the participants in WHI represent a broad ethnic, geographic,
and socioeconomic sample of women in the United States. Finally, this is one of the few
studies to examine whether the relation of VVV of blood pressure and stroke is independent
of blood pressure increases over time.
Perspectives
The results from this large study of generally healthy postmenopausal women suggest that
higher levels of annual VVV of SBP are independently associated with an increased risk of
stroke. The increase in stroke risk is not explained by important factors such as age, race/
ethnicity, CVD risk factors, prevalent CVD, use of antihypertensive medications or hormone
therapy, mean SBP over time, and the temporal trend of SBP. Notably, the association
between VVV of SBP and stroke is stronger among women whose mean SBP is in the
lowest range, which suggests a possible role for measures of VVV of blood pressure in
refining office-based risk assessment. Future studies should identify the causal pathways
that underlie the relation between VVV of SBP and stroke, and investigate the mechanisms
as to why the association between VVV and stroke is stronger in postmenopausal women
with the lowest SBP.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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1. What is new?
• This study examines whether annual VVV of blood pressure is associated with
stroke in postmenopausal women who have a wide range of CVD risk, and
whether this relation is independent of the temporal trend of blood pressure,
which is a factor that contributes to VVV of blood pressure.
• The large sample size facilitates the examination of this relation across several
subgroups.
2. What is Relevant?
• The study examines whether VVV of blood pressure is independently associated
with stroke, an important hypertension-related outcome.
3. Summary
• In postmenopausal women, greater VVV of SBP was independently associated
with increased risk of stroke. A stronger association was observed in those with
mean SBP in the lowest range.
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Figure 1. Representative Patterns of Visit-to-Visit Blood Pressure Variability
Plots illustrate systolic blood pressure (SBP) measures over follow-up of four different
individuals (Panels 1-4) with approximately the same mean SBP across visits. Standard
deviations from the mean and least squares regression line are labeled “SD” and “SDreg”,
respectively. Slope of the regression line is labeled “slope.” SBP at each visit is represented
by black dots. SD is a measure of the VVV of SBP about the individual's mean (solid blue
line), where the mean is assumed to be static. SDreg is a measure of the VVV of SBP about
the individual's regression line (solid red line), where the mean (i.e., regression line) is
assumed to be a linear function of time. Conceptually, SD is the ‘average’ of the deviations
(lengths of dotted blue lines) about the mean (solid blue line), and SDreg is the ‘average’ of
the deviations (lengths of dotted red lines) about the regression line (solid red line). The 2
individuals in Panels 3 and 4 (bottom left and right panels) have a larger temporal change in
SBP across visits than the 2 individuals in Panels 1 and 2 (upper left and right panels). The
individual in Panel 3 has a higher SD from the mean but a similar SDreg from the regression
line, compared to the individual in Panel 1. A similar pattern is seen with the 2 individuals in
Panels 4 and 2. Further, despite having similar mean SBP across visits, the individuals in
Panels 1 and 2, and separately the individuals in Panels 3 and 4, have different SD from the
mean and also different SDreg from the regression line.
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